Torres TN, Tovar-Palacio AR

Language: Spanish
References: 63
Page: 246-254
PDF size: 150.89 Kb.

ABSTRACT

Soy protein has been used in several Latin-American countries including Mexico in various food programs with the purpose to improve the nutritional status of the population due to the high nutritional value and its relatively low cost that was maintained for some time. In the present work, the use and research on soy in Mexico since 1970 is described. In addition, this review shows the effects of the different components of soy, in particular its protein and the isoflavones on health, the mechanism of action of soy protein to reduce cholesterol and triglycerides, and insulin secretion, as well as its glycemic response, and finally, the recommendations of soy protein consumption to obtain a health benefit.

REFERENCES

1. Schrimshaw NS. Fifty-five-year personal experience with human nutrition world wide. Ann Rev Nutr 2007;27:1-18.

2. Bressani R, Viteri F, Elias LG, de Zaghi S, Alvarado J, Odeli AD. Protein quality of a soybean protein textured food in experimental animals and children. J Nutr 1967;93:349-360.

3. Bourges H. El papel de la soya en la alimentación humana. Cuad Nutr 1978;3: 365-371.

4. Del Valle FR, Perez-Villaseñor J. Enrichment of tortillas with soy proteins by lime-cooking of whole raw corn-soybean mixtures. J Food Sci 1974;39:244-249.

5. Bourges H, Morales de León JC. The experience in Mexico on the utilization of non-conventional protein sources. Nutr Food Sci 1980;2:277-287.

6. Morales J, Bourges H, Camacho JL. Utilization of soya protein in highly nutritious low-cost products in Mexico. J Am Oil Chem Soc 1981; 58:374-376.

7. Bourges H. Experiencia del Programa Nacional de Alimentación (México) con el uso de la soya. Primera Conferencia Latinoamericana sobre la proteína de Soya; 1975 nov 10; México, DF.

8. Sarwar G, Peace RW, Botting HG. Corrected relative net protein ratio (CRNPR) method based on differences in rat and human requirements for sulfur amino acids. J Am Oil Chem Soc 1985;68: 689-693.

9. Food and Drug Administration, Department of Health and Human Services and Fed Regist. Food labeling: General requirements for health claims for food, 1991: 60537-60566.

10. Sarwar G, McDonough FE. Evaluation of protein digestibility-corrected amino acid score method for assessing protein quality foods. J Assoc Off Anal Chem 1990;73:347-356.

11. Bodwell CE, Satterlee LD, Hackler LR. Protein digestibility of the same protein preparations by humans and rat assays and by in vitro enzymic digestion methods. J Nutr 1980;33:677-686.

12. Young VR. Soy protein in relation to human protein and aminoacid nutrition. J Am Diet Assoc 1991;91:828-835.

13. Torres N, Quiroz G, Ramos V, Flores I, Solorio M, Tovar AR. Conocimiento y consumo de soya en los habitantes de una zona urbana del Distrito Federal. Nutr Clin 2004;7:221-226.

14. Hoyer H. La soya, la planta maravilla de la naturaleza. El frijol de soya, un regalo de la naturaleza. 5 000 años y todavía irremplazable. México y Centroamérica: Asociación Americana de Soya, 2000: 4.

15. Asociación Americana de Soya. Disponible en: http://www.aces.uiuc.edu/asamex/proteina.html

16. Recommended Dietary Allowances. 10th Edition. Washington, DC: National Academy Press, 1989.

17. Zezulka AY, Calloway DH. Nitrogen retention in men fed varying levels of amino acids from soy protein with or without added L-methionine. J Nutr 1976;106: 212-221.

18. Schrimshaw NS, Young VR. Soy protein in adult human nutrition: a review with new data. New York: Academic Press, 1979; 331-339.

19. Merritt RJ, Jenks BH. Safety of soy-based infant formulas containing isoflavones: The clinical evidence. J Nutr 2004;134:1220S-1224S.

20. Franke AA, Custer LJ, Wang W, Shi CY. HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med 1998;217:263-273.

21. Kuiper GG, Lemmen JG, Carlsson B. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-4263.

22. Setchell KDR, Cassidy A. Dietary isoflavones: Biological effects and relevance to human health. J Nutr 1999;129:758S-767S.

23. Reinli K, Block G. Isoflavone content of soy foods. Nutr Cancer 1996; 26:123-148.

24. Murphy PA, Song T, Buseman G, Barua K, Beecher GR, Trainer D, et al. Isoflavones in retail and institutional soy foods. J Agric Food Chem 1999; 47:2697-2704.

25. Erdman J. Soy protein and cardiovascular disease. A statement for healthcare professionals from the nutrition committe of the AHA. Circulation 2000;102:2555-2559.

26. Nestel PJ, Yamashita T, Sasahara T. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal woman. Arterioscler Thromb Vasc Biol 1997;17:3392-3398.

27. Kurzer MS. Hormonal effects of soy in premenopausal women and men. J Nutr 2002;132:570S-573S.

28. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M, et al. Soy protein, isoflavones, and cardiovascular health. An American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006;113:1034-1044.

29. Noriega-López L, Tovar AR, González-Granillo M, Hernández-Pando R, Escalante B, Santillán-Doherty P, et al. Pancreatic insulin secretion in rats fed a soy protein high fat diet depends on the interaction between the amino acid pattern and isoflavones. J Biol Chem 2007;282:20662-20666.

30. Food and Drug Administration, Department of Health and Human Services and Fed Regist. Health claims. Disponible en: www.cfsan.fda.gov//~dms/fdsoypr.html.

31. Rivera JA, Muñoz-Hernández O, Rosas-Peralta M, Aguilar-Salinas CA, Popkin BM, Willet WC. Consumo de bebidas para una vida saludable: recomendaciones para la población mexicana. Salud Publica Mex 2008;50:173-195.

32. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333: 276-282.

33. Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, et al. AHA Dietary Guidelines. Revision 2000: A Statement for healthcare professionals from the nutrition committee of the American Heart Association. Circulation 2000; 102:2284-2299.

34. Zhan S, Ho SC. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 2005;81:397-408.

35. Torres N, Torre I, Tovar AR. Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders. J Nutr Biochem 2006;17: 365-373.

36. Torre-Villalvazo I, Tovar AR, Ramos-Barragán VE, Cerbon-Cervantes MA, Torres N. Soy protein ameliorates metabolic abnormalities in liver and adipose tissue of rats fed a high fat diet. J Nutr 2008;138:462-468.

37. Tovar AR, Torre I, Ochoa M, Elias AL, Ortiz V, Aguilar C, et al. Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats. J Lipid Res 2005;46:1823-1832.

38. Ascencio C, Torres N, Isoard F, Gomez FJ, Hernandez R, Tovar AR. Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J Nutr 2004;134:522-529.

39. Remer T, Manz F. Estimation of the renal net acid excretion by adults consuming diets containing variable amounts of protein. Am J Clin Nutr 1994;59: 1356-1361.

40. Abelow BJ, Holford TR, Insogna KL. Cross-cultural association between dietary animal protein and hip fracture: A hypothesis. Calcif Tissue Int 1992;50:14-18.

41. Breslau NA, Brinkley L, Hill KD, Pak CY. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab 1988; 66:140-146.

42. Messina MJ. Legumes and soybeans: overview of their nutritional profiles and health effects. Am J Clin Nutr 1999;70 (Suppl):439S-450S.

43. Brandi ML. Flavonoids: Biochemical effects and therapeutic applications. Bone Miner 1992;19 (Suppl):S3-S14.

44. Zhang X, Shu X, Li H, Yang G, Li Q, Gao YT, et al. Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women. Arch Intern Med 2005;165:1890-1895.

45. Tovar AR, Murguía F, Cruz C, Hernandez R, Aguilar C, Pedraza J, et al. A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome. J Nutr 2002;132:2562-2569.

46. Pedraza-Chaverri J, Barrera D, Hernández-Pando R, Medina-Campos ON, Cruz C, Murguía F, et al. Soy protein diet ameloriates renal nitrotirosine formation and chronic nephropathy induced by puromycin aminonucleoside. Life Sci 2004; 74:987-999.

47. Trujillo J, Pérez J, Torre I, Torres N, Tovar AR, Muñoz RM, et al. Renal protection by a soy diet in obese Zucker rats is associated with restoration of nitric oxide generation. Am J Physiol Renal Physiol 2005;288:F108-F116.

48. Kontessis P, Jones S, Dodds R, Trevisan R, Nosadini R, Fioretto P, et al. Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney Int 1990;38:136-144.

49. Position of the American Dietetic Association and Dietitians of Canada: Vegetarian diets. J Am Diet Assoc 2003;103:748-762.

50. Torres N, Palacio-González B, Noriega L, Tovar AR. Índice glicémico, indice insulinémico y carga glicémica de bebidas de soya con un contenido bajo y alto en hidratos de carbono. Rev Invest Clin 2006;58: 489-499.

51. Anderson JW, Smith BM, Washnock CS. Cardiovascular and renal benefits of dry bean and soybean intake. Am J Clin Nutr 1999;70:464S-474S.

52. Wu Z, Rodgers RP, Marshall AG. Characterization of vegetable oils: detailed compositional fingerprints derived from electrospray ionization fourier transform ion cyclotron resonance mass spectrometry. J Agric Food Chem 2004;52:5322-5328.

53. Rodríguez-Cruz M, Tovar AR, Del Prado M, Torres N. Mecanismos moleculares de acción de los ácidos grasos poliinsaturados y sus beneficios en la salud. Rev Invest Clin 2005;57:457-472.

54. United States Department of Agriculture. Nutrient Data Base. Disponible en: http://www.ars.usda.gob. 2008.

55. Bakhit RM, Klein BP, Essex-Sorlie D. Intake of 25 g of soybean protein with or without soybean fiber alters plasma lipids in men with elevated cholesterol concentrations. J Nutr 1994;124:213-222.

56. Rackis JJ. Biological active components. Westport, CT: Publishing Co, 1972; I: 158-202.

57. Potter SM. Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 1995;125:606S-611S.

58. Graf E, Eaton JW. Antioxidant functions of phytic acid. Free Radic Biol Med 1990;8:61-69.

59. Harland BF, Morris ER. Phytate: A good or a bad food component? Nutr Res 1995;15:733-754.

60. Suarez FL, Springfield J, Fume JK. Gas production in humans ingesting a soybean fluor derived from beans naturally low in oligosaccharides. Am J Clin Nutr 1999;69:135-139.

61. Koo M, Rao AV. Long term effect of bifidobacteria and neosugar on precursor lesions. Nutr Cancer 1991;16:249-257.

62. Mitsuoka T. Recent trends in research on intestinal flora. Bifidob Micro 1982;1: 3-24.

63. Nutrient data laboratory FCL, Beltsville Human Nutrition Research Center, Agricultural Research Service. U.S, Department of Agriculture, USDA-Iowa Stae University Database on the Isoflavone content of foods. Disponible en: http://www.ars.usda.gov/nutrientdata. 2007.